针对小卵性前列腺癌的局部治疗
Taketo Kawai1,2, Satoru Taguchi2, Tohru Nakagawa3
1Department of Urology, International University of Health and Welfare Ichikawa Hospital, 6-1-14 Konodai, Ichikawa, Chiba 272-0827, Japan.
Japanese journal of clinical oncology
|March 15, 2025
概括
先进的成像检测到寡头前列腺癌,使局部疗法. 研究表明,这些治疗改善了转移性前列腺癌各个阶段的存活率和无进展存活率.
科学领域:
- 在瘤学瘤学.
- 辐射疗法 辐射疗法
- 医疗成像医学成像
背景情况:
- 转移性前列腺癌传统上是用抗雄激素缺乏疗法 (ADT) 治疗的.
- 对转移性病变的局部疗法很少使用.
- 下一代成像 (例如PSMA-PET) 现在可以检测到以前无法检测到的寡头转移.
研究的目的:
- 审查前列腺癌的局部疗法的作用和证据.
- 突出先进成像对治疗策略的影响.
- 讨论前列腺癌转移管理局部治疗的未来.
主要方法:
- 随机对照试验 (RCT) 的证据审查,包括STAMPEDE,STOMP,ORIOLE和ARTO.
- 分析像PSMA-PET这样的先进成像模式的影响.
- 精髓瘤前列腺癌的分类为新生,精髓瘤和精髓瘤进展型.
主要成果:
- STAMPEDE试验显示,在ADT中添加前列腺放射治疗,改善了新发低体积转移性前列腺癌的整体存活率.
- STOMP和ORIOLE试验表明,转移导向疗法可显著延长寡度前列腺癌的无进展生存期 (PFS).
- ARTO试验表明,将放射疗法添加到寡头转移剂中,可以改善PFS在寡头进步的抵抗割的前列腺癌中.
结论:
- 局部疗法对于小卵性前列腺癌越来越重要,并得到RCT证据的支持.
- 像PSMA-PET这样的先进成像技术有助于识别和治疗寡头转移.
- 预计对原发性瘤和转移的局部治疗将成为未来的一个突出策略.
相关概念视频
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Cancer Therapies
7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K
Tumor Immunotherapy
457
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
457


